Log in

NeuroVive Pharmaceutical News Headlines (OTCMKTS:NEVPF)

$0.15
0.00 (0.00 %)
(As of 10/18/2019 04:00 PM ET)
Today's Range
$0.15
Now: $0.15
$0.15
50-Day Range
$0.13
MA: $0.19
$0.22
52-Week Range
$0.10
Now: $0.15
$0.49
Volume100 shs
Average Volume225 shs
Market Capitalization$7.80 million
P/E RatioN/A
Dividend YieldN/A
Beta1.95

Headlines

NeuroVive Pharmaceutical (OTCMKTS NEVPF) News Headlines

Source:
DateHeadline
We Think NeuroVive Pharmaceutical (STO:NVP) Needs To Drive Business Growth CarefullyWe Think NeuroVive Pharmaceutical (STO:NVP) Needs To Drive Business Growth Carefully
finance.yahoo.com - September 26 at 2:42 PM
How Does Investing In NeuroVive Pharmaceutical AB (STO:NVP) Impact The Volatility Of Your Portfolio?How Does Investing In NeuroVive Pharmaceutical AB (STO:NVP) Impact The Volatility Of Your Portfolio?
finance.yahoo.com - August 23 at 4:17 PM
NeuroVive Pharmaceutical AB Interim Report January - June 2019NeuroVive Pharmaceutical AB Interim Report January - June 2019
www.prnewswire.com - August 21 at 3:52 AM
Save the Date: NeuroVive to host Capital Markets Day in Stockholm on 9 October, 2019Save the Date: NeuroVive to host Capital Markets Day in Stockholm on 9 October, 2019
www.prnewswire.com - August 20 at 7:43 AM
NeuroVives NeuroSTAT Project Receives FDA Fast Track DesignationNeuroVive's NeuroSTAT Project Receives FDA Fast Track Designation
www.prnewswire.com - July 27 at 7:43 AM
NeuroVive Initiates Second Part of its Ongoing KL1333 Phase Ia/b Clinical StudyNeuroVive Initiates Second Part of its Ongoing KL1333 Phase Ia/b Clinical Study
www.prnewswire.com - July 4 at 9:17 AM
Catalyst Pharma (CPRX) Rides on Successful Launch of FirdapseCatalyst Pharma (CPRX) Rides on Successful Launch of Firdapse
finance.yahoo.com - May 22 at 4:28 PM
NeuroVive Pharmaceutical AB Interim Report January - March 2019NeuroVive Pharmaceutical AB Interim Report January - March 2019
finance.yahoo.com - May 21 at 12:27 PM
NeuroVives IND for Clinical Development of NeuroSTAT Approved by FDANeuroVive's IND for Clinical Development of NeuroSTAT Approved by FDA
www.prnewswire.com - May 10 at 3:49 AM
NeuroVive Pharmaceutical AB Publishes 2018 Annual ReportNeuroVive Pharmaceutical AB Publishes 2018 Annual Report
finance.yahoo.com - March 25 at 11:30 AM
NeuroVive Enrolls First Subject in its KL1333 Phase Ia/b Clinical StudyNeuroVive Enrolls First Subject in its KL1333 Phase Ia/b Clinical Study
www.prnewswire.com - March 19 at 4:04 AM
NeuroVive Receives SEK 28.2 Million in a Directed New Share IssueNeuroVive Receives SEK 28.2 Million in a Directed New Share Issue
finance.yahoo.com - March 7 at 12:16 PM
NeuroVive Enters Commercial Partnership With Oroboros Instruments on Mitochondrial Medicine Research CompoundsNeuroVive Enters Commercial Partnership With Oroboros Instruments on Mitochondrial Medicine Research Compounds
finance.yahoo.com - February 21 at 1:01 PM
NeuroVive nabs funding for NV354; shares up 9%NeuroVive nabs funding for NV354; shares up 9%
seekingalpha.com - November 15 at 10:30 AM
NeuroVive Receives Vinnova Funding to Support Development of NV354, a Novel Treatment for Genetic Mitochondrial DisordersNeuroVive Receives Vinnova Funding to Support Development of NV354, a Novel Treatment for Genetic Mitochondrial Disorders
finance.yahoo.com - November 15 at 10:30 AM
NeuroVive Today Announces That the Subscription Period for Warrants of Series 2018:1 Will Begin on Thursday, November 1NeuroVive Today Announces That the Subscription Period for Warrants of Series 2018:1 Will Begin on Thursday, November 1
finance.yahoo.com - October 31 at 10:39 AM
NeuroVive Receives KL1333 Clinical Trial Regulatory ApprovalNeuroVive Receives KL1333 Clinical Trial Regulatory Approval
finance.yahoo.com - October 10 at 10:13 AM
Who Are The Major Shareholders Of NeuroVive Pharmaceutical AB (STO:NVP)?Who Are The Major Shareholders Of NeuroVive Pharmaceutical AB (STO:NVP)?
finance.yahoo.com - September 14 at 10:30 AM
NeuroVive Receives Positive FDA Feedback on its NeuroSTAT TBI Development PlanNeuroVive Receives Positive FDA Feedback on its NeuroSTAT TBI Development Plan
www.prnewswire.com - September 6 at 3:28 AM
NeuroVives NVP015 Program Will be Accelerated Through Award of Major Research Grant to Childrens Hospital of PhiladelphiaNeuroVive's NVP015 Program Will be Accelerated Through Award of Major Research Grant to Children's Hospital of Philadelphia
finance.yahoo.com - August 28 at 10:23 AM
NeuroVive Pharmaceutical AB Interim Report January - June 2018NeuroVive Pharmaceutical AB Interim Report January - June 2018
www.prnewswire.com - August 21 at 4:49 AM
NeuroVive Out-licenses Targeted LHON Therapy to BridgeBio Pharmas New Subsidiary Fortify TherapeuticsNeuroVive Out-licenses Targeted LHON Therapy to BridgeBio Pharma's New Subsidiary Fortify Therapeutics
finance.yahoo.com - August 15 at 10:37 AM
NeuroVive out-licenses targeted LHON therapy to Fortify TherapeuticsNeuroVive out-licenses targeted LHON therapy to Fortify Therapeutics
seekingalpha.com - June 18 at 12:58 PM
NeuroVive Pharmaceutical AB Interim Report January - March 2018NeuroVive Pharmaceutical AB Interim Report January - March 2018
finance.yahoo.com - May 22 at 10:29 AM
NeuroVives KL1333 shows encouraging action in early-stage study; shares up 11%NeuroVive's KL1333 shows encouraging action in early-stage study; shares up 11%
seekingalpha.com - May 21 at 3:28 PM
NeuroVive and Yungjin Reports Positive KL1333 Phase I Clinical Study Results Paving the way for Further Clinical DevelopmentNeuroVive and Yungjin Reports Positive KL1333 Phase I Clinical Study Results Paving the way for Further Clinical Development
finance.yahoo.com - May 21 at 10:38 AM
NeuroVive Initiates Collaboration With Leading US TBI Research OrganizationNeuroVive Initiates Collaboration With Leading US TBI Research Organization
finance.yahoo.com - May 2 at 10:33 AM
Resolutions From Annual General Meeting in NeuroVive Pharmaceutical AB (publ)Resolutions From Annual General Meeting in NeuroVive Pharmaceutical AB (publ)
finance.yahoo.com - April 27 at 10:33 AM
Amendment: Resolutions From Annual General Meeting in NeuroVive Pharmaceutical AB (publ)Amendment: Resolutions From Annual General Meeting in NeuroVive Pharmaceutical AB (publ)
finance.yahoo.com - April 27 at 10:33 AM
NeuroVives Partner Yungjin Pharm Completes KL1333 Phase I Study RecruitmentNeuroVive's Partner Yungjin Pharm Completes KL1333 Phase I Study Recruitment
finance.yahoo.com - April 17 at 10:03 AM
Are Earnings Prospects Improving For Loss-Making NeuroVive Pharmaceutical AB’s (STO:NVP)?Are Earnings Prospects Improving For Loss-Making NeuroVive Pharmaceutical AB’s (STO:NVP)?
finance.yahoo.com - March 17 at 9:45 AM
NeuroVive Decides on a Rights Issue for Continued Drug DevelopmentNeuroVive Decides on a Rights Issue for Continued Drug Development
finance.yahoo.com - February 15 at 9:45 AM
Notice of Extraordinary General Meeting of NeuroVive Pharmaceutical AB (publ)Notice of Extraordinary General Meeting of NeuroVive Pharmaceutical AB (publ)
finance.yahoo.com - February 15 at 9:45 AM
NeuroVive Reports Breakthrough in Mitochondrial Myopathy ProjectNeuroVive Reports Breakthrough in Mitochondrial Myopathy Project
finance.yahoo.com - January 29 at 8:06 AM
NeuroVive to Present at the 10th Annual Biotech Showcase ConferenceNeuroVive to Present at the 10th Annual Biotech Showcase Conference
finance.yahoo.com - January 11 at 5:46 PM
NeuroVive Reports Promising Progress in its Clinical Project for Genetic Mitochondrial Diseases, KL1333NeuroVive Reports Promising Progress in its Clinical Project for Genetic Mitochondrial Diseases, KL1333
finance.yahoo.com - December 11 at 9:52 AM
NeuroVives Genetic Mitochondrial Disease Program NVP015 Reaches Significant MilestoneNeuroVive's Genetic Mitochondrial Disease Program NVP015 Reaches Significant Milestone
finance.yahoo.com - November 30 at 9:17 AM
Amended Number of Shares and Votes in NeuroVive Pharmaceutical AB (publ)Amended Number of Shares and Votes in NeuroVive Pharmaceutical AB (publ)
finance.yahoo.com - November 30 at 9:17 AM
NeuroVive Presents TBI Clinical Study Results at Nordic Neurotrauma ConferenceNeuroVive Presents TBI Clinical Study Results at Nordic Neurotrauma Conference
finance.yahoo.com - November 15 at 6:44 AM
This page was last updated on 10/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel